BTK InhibitorPharmaceutical InformationUpdated on Apr 11, 2019 View more like this | Visit SHIRLEY, NY | Contact BOCSCI INC |
BOC Sciences offers BTK Inhibitors for research use.
Bruton's tyrosine kinase (BTK) is a cytoplasmic, non-receptor tyrosine kinase that transmits signals from a variety of cell-surface molecules, including the B-cell receptor (BCR) and tissue homing receptors. Genetic BTK deletion causes B-cell immunodeficiency in humans and mice, making this kinase an attractive therapeutic target for B-cell disorders.
Bruton's tyrosine kinase (BTK) is a cytoplasmic, non-receptor tyrosine kinase that transmits signals from a variety of cell-surface molecules, including the B-cell receptor (BCR) and tissue homing receptors. Genetic BTK deletion causes B-cell immunodeficiency in humans and mice, making this kinase an attractive therapeutic target for B-cell disorders.
